focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarble Point L. Regulatory News (MPLF)

Share Price Information for Marble Point L. (MPLF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.63
Bid: 0.59
Ask: 0.67
Change: 0.00 (0.00%)
Spread: 0.08 (13.559%)
Open: 0.63
High: 0.63
Low: 0.63
Prev. Close: 0.63
MPLF Live PriceLast checked at -
Marble Point Loan Financing is an Investment Trust

To generate stable current income and to grow NAV by earning a return on equity in excess of the amount distributed as dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Announcement

18 Aug 2023 16:36

RNS Number : 8278J
Marble Point Loan Financing Limited
18 August 2023
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS OR IN THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSONS, WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW.

 

18 August 2023

 

Marble Point Loan Financing Limited

Liquidating Share Class Distribution

The Directors of Marble Point Loan Financing Limited (the "Company") have announced a distribution to holders of the Company's Liquidating Shares created via redesignation of Ordinary Shares effective on the Conversion Date 1 January 2023 (such Liquidating Shares hereinafter referred to as the "2023 Liquidating Shares") of $0.0356 per 2023 Liquidating Share. The distribution will be payable to holders of the Company's 2023 Liquidating Shares as detailed below:

 

Distribution[1]:

$0.0356 per 2023 Liquidating Share

Record Date:

21 August 2023

Payment Date:

31 August 2023

Liquidating Shares Outstanding[2]

49,741,723

 

Past performance is not indicative, or a guarantee, of future performance.

This release contains inside information.

ENQUIRIES

Marble Point Loan Financing Limited

Investor Relations

Tel.: +44 (0) 20 7259 1500

Email:  ir@mplflimited.com

Corporate Broker

Stifel Nicolaus Europe Limited

T: +44 (0) 20 7710 7600

 

 

 

 

 

 

 

 

 

 

 

 

 

About Marble Point Loan Financing Limited

Marble Point Loan Financing Ltd. (LSE Ticker: MPLF LN (USD); MPLS LN (GBX)) is a Guernsey-domiciled closed-ended investment company. MPLF's investment objective is to generate stable current income and grow net asset value by earning a return on equity in excess of the amount distributed as dividends. For more information, please visit the Company's website:  www.mplflimited.com

 LEI: 549300DWXSN5UC85CL26

MPLF is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans owned via collateralised loan obligations ("CLOs") and related vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission. 

About Marble Point Credit Management LLC

Marble Point Credit Management LLC ("Marble Point") is a specialist asset manager focused exclusively on leveraged loans. Marble Point is 100% owned by Investcorp International Holdings Inc. ("IIHI"), which is part of the Investcorp Group of companies. The Investcorp Group effectively operates as a management-controlled group, substantially all whose assets and operations are owned and controlled by Investcorp S.A., a company domiciled in the Cayman Islands. Investcorp Holdings B.S.C. ("Investcorp") a Bahrain based holding company is the parent company of Investcorp S.A. ("S.A."). Certain of the Investcorp Group's directors and senior executive officers have the ability to indirectly control Investcorp S.A.

IMPORTANT INFORMATION

This document is provided for informational purposes only and does not constitute an offer to sell any shares, notes or other securities (collectively, "Securities") issued by the Company or a solicitation of an offer to purchase any such Securities in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction. This document may not be relied upon, and should not be used, for the purpose of making any investment decision. Securities issued by the Company have not been and will not be registered under the U.S. Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered or sold in the United States to, or for the account or benefit of, U.S. persons unless they are registered under applicable law or exempt from registration. The Company has not been and will not be registered under the U.S. Investment Company Act of 1940 and investors will not be entitled to the benefits of such Act. No recipient may forward, reproduce, distribute, or make available in whole or in part, this document (directly or indirectly) to any other person. The distribution of this document in certain jurisdictions may be restricted by law and recipients of this document should inform themselves about and observe any such restrictions and other applicable legal requirements in their jurisdictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States or the laws of other jurisdictions. 

Past performance is not a reliable indicator of current or future results. The value of investments may go down as well as up and investors may not get back any of the amount invested. The value of investments designated in another currency may rise and fall due to exchange rate fluctuations in respect of the relevant currencies. Adverse movements in currency exchange rates can result in a decrease in return and a loss of capital.

There is no guarantee that any of the goals, targets or objectives described in this document will be achieved. The investment strategies of the Company described herein may not be suitable for all investors and are not intended to constitute a complete investment program. Neither Marble Point nor the Company makes any representation or warranty (express or implied) with respect to the information contained herein (including, without limitation, information obtained from third parties) and each of them expressly disclaims any and all liability based on or relating to the information contained in, or errors or omissions from, these materials; or based on or relating to the use of these materials; or any other written or oral communications transmitted to the recipient or any of its affiliates or representatives in the course of its evaluation of the information herein.

None of the Company, Marble Point or any of their respective parent or subsidiary undertakings, or the subsidiary undertaking of any such parent undertakings, or any of such person's respective partners, shareholders, directors, members, officers, affiliates, agents, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any information or opinions presented or contained in this document nor shall they accept any responsibility whatsoever for, or make any warranty, express or implied, as to the truth, fullness, accuracy or completeness of the information in this document (or whether any information has been omitted from the document) or any other information relating to the Company, Marble Point or their respective subsidiaries or associated companies, in any form whatsoever, howsoever transmitted or made available or for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection therewith. This shall not affect any liability any such person may have which may not be excluded under applicable law or regulation.

A Note on Forward Looking Statements. This document includes forward-looking statements. Forward-looking statements include all matters that are not historical facts. Actual results may differ materially from any results projected in the forward-looking statements and are subject to risks and uncertainties. Such statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, and other factors that may cause actual results to differ materially from the anticipated results expressed or implied by such forward-looking statements. The Company and Marble Point caution readers not to place undue reliance on such statements. Neither the Company nor Marble Point undertakes, and each specifically disclaims, any obligation or responsibility, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from the Company's and/or Marble Point's expectations and estimates.

The information provided herein is estimated, unaudited, for background purposes only, representative as at the dates specified herein, subject to adjustment and not purported to be full or complete. Nothing herein shall be relied upon as a representation as to the current or future performance or portfolio holdings of the Company or any strategy or investment vehicle. Certain information presented herein has been obtained from third party sources and is believed to be reliable. However, neither the Company nor Marble Point represents that the information contained in this document (including third party information) has been independently verified or is accurate or complete, and it should not be relied upon as such. Index information, if any, has been provided for illustration purposes only. Any such information does not reflect the effect of transaction costs, management fees or other costs which would reduce returns. An investor cannot invest directly in an index.

Any of the views or opinions expressed herein are current views and opinions only and may be subject to change. Statements made herein are as of the date of this document and should not be relied upon as of any subsequent date. All information is current as of the date of this document and is subject to change without notice.

 

 


[1] The Company pays distributions in U.S. Dollars. Shareholders will, by default, receive their cash distributions in U.S. Dollars.

[2] On 1 January 2023, 49,741,723 of the Company's Ordinary Shares were redesignated to its Liquidating Share Class. As at the date of this announcement, 149,225,169 Ordinary Shares remain outstanding.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVETEITLIV
Date   Source Headline
25th Apr 20244:51 pmRNSSterling Dividend Amount
23rd Apr 20247:00 amRNSNet Asset Value & Publication of Monthly Report
12th Apr 20245:01 pmRNSAnnual Financial Report
4th Apr 20247:00 amRNSDividend Declaration
25th Mar 20246:00 pmRNSNet Asset Value & Publication of Monthly Report
13th Mar 20247:00 amRNSIssue of Equity from Treasury - Amending RNS 3485F
1st Mar 20245:47 pmRNSMPLF Issue of Equity from Treasury
27th Feb 20247:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Feb 20244:33 pmRNSNotice of Results of Extraordinary General Meeting
20th Feb 20247:00 amRNSLiquidating Share Class Distribution
29th Jan 20244:06 pmRNSCarey Commercial Limited – Change of Name
29th Jan 20247:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jan 20246:00 pmRNSNotice of GM
18th Jan 20244:30 pmRNSSterling Dividend Amount
27th Dec 20237:00 amRNSNet Asset Value & Publication of Monthly Report
27th Dec 20237:00 amRNSDividend Declaration
28th Nov 20236:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Nov 20237:00 amRNS3rd Quarter Results
17th Nov 20236:00 pmRNSLiquidating Share Class Distribution
17th Nov 20237:00 amRNSResults of Annual General Meeting (“AGM”)
30th Oct 20237:00 amRNSNotice of Annual General Meeting (“AGM”)
24th Oct 20236:00 pmRNSNet Asset Value & Publication of Monthly Report
20th Oct 20235:02 pmRNSDividend Declaration
28th Sep 20237:00 amRNSDividend Declaration
25th Sep 20237:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20236:00 pmRNSHalf-Yearly Report
23rd Aug 20237:00 amRNSNet Asset Value & Publication of Monthly Report
18th Aug 20234:36 pmRNSDistribution Announcement
27th Jul 20233:55 pmRNSMPLF - Key Information Document (KID)
21st Jul 20236:00 pmRNSDividend Declaration
20th Jul 20237:00 amRNSNet Asset Value & Publication of Monthly Report
29th Jun 20237:00 amRNSDividend Declaration
26th Jun 20236:02 pmRNS1st Quarter Results
23rd Jun 20235:30 pmRNSAnnouncement of Corporate Actions
23rd Jun 20237:00 amRNSNet Asset Value & Publication of Monthly Report
19th May 20231:36 pmRNSRevolving Credit Facility Extension
19th May 20237:00 amRNSNet Asset Value & Publication of Monthly Report
15th May 20234:31 pmRNSDistribution Announcement
24th Apr 20235:30 pmRNSSterling Dividend Amount
21st Apr 20235:00 pmRNSNet Asset Value & Publication of Monthly Report
12th Apr 20236:00 pmRNSAnnual Financial Report
11th Apr 20234:10 pmRNSHolding(s) in Company
30th Mar 20234:10 pmRNSDividend Declaration
23rd Mar 20237:00 amRNSNet Asset Value & Publication of Monthly Report
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Feb 20237:00 amRNSLiquidating Share Class Distribution Announcement
22nd Feb 20237:00 amRNSNet Asset Value & Publication of Monthly Report
30th Jan 20237:00 amRNSHolding(s) in Company
23rd Jan 20237:00 amRNSNet Asset Value & Publication of Monthly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.